Norwegian retailers Norgesgruppen, Rema 1000, and Coop Norge are facing revised fines totaling a preliminary Nkr4.9 billion ($450.6 million) in a long-standing legal battle dating back to 2020.
The Competition Authority, Konkurransetilsynet, initially slapped the trio with combined fines of Nkr21 billion in 2020, alleging collusion to fix prices after an investigation launched in 2018. The regulator claimed that the retailers facilitated each other’s “price hunters” to gather pricing data, resulting in restricted competition and higher prices.
Konkurransetilsynet’s Director General, Tina Søreide, stated that the preliminary fines have been reduced, but emphasized that the assessment of competition restriction persists.
The revised fines, subject to objections, are Nkr2.3 billion for Norgesgruppen, Nkr1.3 billion for Rema, and another Nkr1.3 billion for Coop, marking a significant reduction from the original fines.
Read more: Norwegian Retailers’ Antitrust Fines Slashed
Ingvill Størksen, Coop’s Director of Policy and Government Relations, expressed disbelief over the regulator’s claims, defending the use of price hunters as fostering competition and benefiting consumers with lower prices and a wider selection.
As the May 2nd deadline for objections approaches, the retailers are preparing to challenge the regulator’s assertions, setting the stage for a protracted legal battle, highlighting an ongoing scrutiny of business practices in Norway’s grocery market.
Source: Global Data
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan